Elicera Therapeutics AB (publ) (FRA:8E8)

Elicera Therapeutics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	24.85	26.4	29.38	43.82	52.39
Cash & Short-Term Investments	24.85	26.4	29.38	43.82	52.39
Cash Growth	-5.88%	-10.15%	-32.95%	-16.36%	353.04%
Other Receivables	2.57	0.88	0.34	0.33	0.2
Receivables	2.57	0.88	0.34	0.33	0.2
Prepaid Expenses	-	0.28	0.45	1.65	1.62
Other Current Assets	-	-	-	-0	-0.01
Total Current Assets	27.42	27.57	30.17	45.8	54.21
Long-Term Investments	-	0	0	0.48	0.48
Other Intangible Assets	-	-	0.01	0.02	0.04
Other Long-Term Assets	-	-	-	-0	0.01
Total Assets	27.42	27.57	30.18	46.31	54.74
Accounts Payable	2.57	2.04	0.88	0.73	2.05
Accrued Expenses	1.24	4.4	12.5	12.53	0.31
Current Income Taxes Payable	-	-	-	0.01	0
Other Current Liabilities	0.25	0.35	0.4	0.24	0.14
Total Current Liabilities	4.06	6.8	13.78	13.51	2.5
Total Liabilities	4.06	6.8	13.78	13.51	2.5
Common Stock	2.04	1.47	0.83	0.83	0.83
Additional Paid-In Capital	106.06	86.62	66.79	66.79	66.79
Retained Earnings	-84.73	-67.33	-51.22	-34.82	-15.38
Comprehensive Income & Other	-	-	-	-0	-0
Shareholders' Equity	23.36	20.77	16.4	32.8	52.24
Total Liabilities & Equity	27.42	27.57	30.18	46.31	54.74
Net Cash (Debt)	24.85	26.4	29.38	43.82	52.39
Net Cash Growth	-5.88%	-10.15%	-32.95%	-16.36%	353.04%
Net Cash Per Share	0.55	0.84	1.49	2.21	3.27
Filing Date Shares Outstanding	48.54	35.09	19.78	19.78	19.78
Total Common Shares Outstanding	48.54	35.09	19.78	19.78	19.78
Working Capital	23.36	20.77	16.39	32.29	51.71
Book Value Per Share	0.48	0.59	0.83	1.66	2.64
Tangible Book Value	23.36	20.77	16.39	32.78	52.2
Tangible Book Value Per Share	0.48	0.59	0.83	1.66	2.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.